This in-depth discussion among experts explores various facets of leukemia management. The conversation spans topics including challenges in clonotypable patients, the significance of MRD negativity in high-risk genetics, and the ongoing debate surrounding the necessity of transplantation for specific patient groups.
REGISTER NOW TO JOIN US AT THESE UPCOMING EVENTS
AML-ALL US – Online content available – https://aml-allus2023.md-education.com/register/
AML-ALL EU – Registration open – https://aml-alleu2023.md-education.com/register/
MPN-MDS EU – registration open – https://mpn-mdseu2023.md-education.com/register/
The experts also touch on practical considerations, such as the frequency of peripheral blood monitoring compared to bone marrow assessments.